Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.10 and traded as low as $0.0779. Sernova Biotherapeutics shares last traded at $0.0779, with a volume of 31,360 shares.
Sernova Biotherapeutics Trading Down 5.0%
The firm’s fifty day moving average price is $0.10 and its 200-day moving average price is $0.11. The firm has a market cap of $29.42 million, a price-to-earnings ratio of -1.95 and a beta of 0.82.
Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last announced its quarterly earnings results on Thursday, June 11th. The company reported ($0.01) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.01).
Sernova Biotherapeutics Company Profile
Sernova Biotherapeutics is a clinical‐stage biotechnology company focused on developing and commercializing cell‐based therapeutic technologies for patients with chronic and life‐threatening diseases. Headquartered in London, Ontario, Canada, the firm is advancing an implantable device platform designed to support the long-term survival and function of therapeutic cells. The company’s lead product candidate, known as the Cell Pouch System, is engineered to create a vascularized environment in which transplanted cells can thrive, with an initial emphasis on treating patients with type 1 diabetes.
In its core program, Sernova has initiated a Phase I/II clinical trial evaluating the safety and efficacy of the Cell Pouch System in individuals with type 1 diabetes who require islet cell transplantation.
Featured Articles
- Five stocks we like better than Sernova Biotherapeutics
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
